• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAREFUSION ALARIS PUMP MODULE ADMINSTRATION SET; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAREFUSION ALARIS PUMP MODULE ADMINSTRATION SET; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Model Number 2123-0007
Device Problems Air Leak (1008); Excess Flow or Over-Infusion (1311)
Patient Problems Hyperglycemia (1905); Low Blood Pressure/ Hypotension (1914); Respiratory Acidosis (2482)
Event Date 05/01/2016
Event Type  malfunction  
Event Description
The following event is from two perspectives.The first perspective: upon initial assessment of the patient at approximately 0815, tpn bag was noted to be empty and there was air in the infusion set line.The tpn infusion was running at 4.6cc/hr on the alaris pump as reported.Immediately, i stopped the infusion and left the lipids to run into the uvc to prevent backflow of blood.Flex rn was called along with medical staff.Labs sent and initial glucose was critical value of 990, vs obtained.Electively intubated based on initial vbg for which she received morphine and ativan.Lower bp's followed and thought to be related to sedation for which she received 0.9 ns bolus x2.Hourly glucose monitoring occurred and d10w.45 with heparin started once glucose in 200 range.They remained appropriate and have been checked with gases.Vs since normalized.Baby has been responsive, moves all extremities (mae's), active with cares; vent weans made following 1700 vbg.Parents updated fully, asking lots of questions.Risk management notified via charge rn.Alaris pump left running until picked up by engineering.The second perspective: premature infant, who was admitted/born at 856pm and admitted to the neonatal intensive care unit for management of prematurity in the setting of preterm premature rupture of the membranes (pprom) and chorioamnionitis.The morning of this event, tpn was found to have infused at > 2x desired rate.Stat vbg, complete metabolic panel (cmp), mag, and phos obtained.Vbg showed 7.037/83.6/32.9, sodium 137, potassium 5.1, calcium 1.71, and lactate 7.6.Given respiratory acidosis she was intubated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALARIS PUMP MODULE ADMINSTRATION SET
Type of Device
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
CAREFUSION
10020 pacific mesa blvd
san diego CA 92121
MDR Report Key5849561
MDR Text Key51261909
Report Number5849561
Device Sequence Number1
Product Code FPA
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source User Facility
Reporter Occupation Other
Type of Report Initial
Report Date 07/20/2016,07/28/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/05/2016
Is this a Product Problem Report? Yes
Device Operator No Information
Device Model Number2123-0007
Other Device ID Number2 Y-SITE 102IN DEHPFREE
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? Yes
Date Report Sent to FDA07/20/2016
Event Location Hospital
Date Report to Manufacturer07/20/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Other;
-
-